查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1714627

生医材料市场按类型、分类、应用和最终用户划分－2025-2030 年全球预测

Biomaterials Market by Type, Classification, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年生医材料市场价值将达499.4亿美元，2025年成长至560.7亿美元，复合年增长率为12.52%，到2030年将达到1013.7亿美元。

主要市场统计数据
基准年2024年 499.4亿美元
预计2025年 560.7亿美元
预测年份 2030 1013.7亿美元
复合年增长率（%） 12.52%

在当今快速发展的技术和生物医学环境中，生医材料已成为医疗保健、研究和工业应用创新的关键参与者。在科学突破和对能够与生物系统无缝互动的材料的需求不断增长的推动下，该领域正在经历指数级增长。近年来，研究人员和产业领袖已转向利用生医材料来应对医疗设备製造、组织工程和再生医学的挑战。这项进展不仅是先进研究技术的结果，也是各行各业对永续高性能材料的迫切需求。

现代生医材料市场结合了先进的复合材料、自然资源、工业聚合物和尖端製造流程。这种技术的融合重新定义了这些材料的期望和应用。我们不仅改善了患者的医疗结果，而且还透过在消费品和建筑行业提供更环保的替代品来帮助减少对环境的影响。透过严格的测试、跨学科合作和实际部署，生医材料格局正在快速转变。

将生物材料整合到各种应用中不仅需要对材料科学有深入的了解，还需要有策略性眼光来发挥其潜力。无论是开发与人体组织非常相似的植入，还是为工业应用创造保护涂层，生医材料的进步正在重塑未来。随着市场持续经历动态成长，相关人员热衷于整合创新和行业标准，以确保产品部署的安全性和效率。

改变生医材料市场

最近的趋势是生医材料领域发生重大变化，变革性变化影响着产品生命週期的每个阶段，从研发到製造和商业化。 3D 列印和奈米技术等新兴技术使得设计具有无与伦比精度的材料成为可能。这些创新支援的产品设计不仅更实用、更耐用，还能满足特定的医疗和工业需求。

最有影响力的变化之一是将先进的模拟工具和资料分析整合到材料设计过程中。这些工具现在通常用于预测材料行为、优化性能以及缩短从概念到市场的时间。因此，对自动化流程和数位转型的投资正在蓬勃发展。监管机构也在更新框架，以更好地解决新型生医材料的复杂性，并鼓励创新，同时保持严格的安全标准。

此外，世界各地的市场领导者和研究机构正在合作，将下一代生医材料推向科学前沿。这些合作的重点是生产不仅具有临床效果，而且永续且具有成本效益的材料。个人化医疗的兴起和对针对患者的具体解决方案的日益重视进一步凸显了定製材料特性的必要性。利用多学科专业知识的统一策略有望推动产业走向生医材料能够快速适应临床和工业挑战的未来。

这项变革时期凸显了重新思考传统方法的迫切性。随着新趋势与传统方法的融合，生医材料领域正在经历一段充满创造性和动态变化的时期，为长期成长和应用适应做好准备。

洞察推动市场动态的关键细分领域

对生物材料市场进行彻底的研究可以发现许多细分方法，这些方法对于理解其多样化性质至关重要。基于类型的细分研究材料，例如陶瓷、金属化合物、天然物质、聚合物等。这些成分中的每一种都表现出独特的特性，可满足高性能和成本敏感市场中的不同应用需求。除此之外，市场细分将市场分为生物活性材料、生物相容性材料和生物钝性材料。这种划分对于区分那些与生物系统有主动相互作用的材料和那些仅仅设计为惰性的材料非常重要。

市场区隔的一个同样重要的面向是基于应用的划分。该镜头检验了生物材料在心血管植入、牙科应用、整形外科植入、外科缝合线、组织工程和伤口处理等领域的相关性。基于应用的细微差别为如何客製化生医材料以改善各种临床环境中的治疗结果提供了清晰的观点。此外，透过将组织特定要求与材料属性连结起来，相关人员可以更好地确定研究重点和创新路径。

为了补充这些见解，基于最终用户的细分可以揭示这些材料的最终受益者。市场已经针对生物技术公司、医院、研究实验室和专科诊所的需求进行了仔细的研究。这种细分可以鸟瞰客户需求和技术适应性。本质上，这些不同但相互关联的细分策略不仅显示了生医材料产业的当前方向，而且还可作为策略性市场规划和研发倡议的蓝图。

这些细分标准突显了生医材料市场高度分散但又综合的性质，并突显了加速创新、投资和市场扩张的潜在领域。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 慢性病的增加推动了对改进生物医学材料的需求
      • 对永续、环保产品的需求不断增长，推动了生医材料的采用
      • 扩大对永续和清洁生产的监管支持和政府奖励
    • 限制因素
      • 可扩展性有限，製造和开发成本高
    • 机会
      • 加大对生物技术研究的投入，推动新生医材料的创新
      • 新兴创新材料加工技术可提高效率
    • 任务
      • 对生物相容性和长期安全性的担忧
  • 市场区隔分析
    • 类型：增加使用具有耐热性和电绝缘性能的陶瓷
    • 应用：心血管领域的扩张正在推动对生医材料的需求。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章生医材料市场（按类型）

  • 陶瓷
  • 金属
  • 自然的
  • 聚合物

第七章生医材料市场（依类别）

  • 生物活性材料
  • 生物相容性材料
  • 惰性材料

第八章生医材料市场（按应用）

  • 心血管系统
  • 牙科应用
  • 整形外科植入
  • 手术缝合线
  • 组织工程
  • 伤口处理

第九章生医材料市场（按最终用户）

  • 生技公司
  • 医院
  • 研究部门
  • 专科诊所

第 10 章：美洲生医材料市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太生医材料市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 12 章欧洲、中东和非洲生医材料市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Ametex Inc.
  • B. Braun Melsungen AG
  • BASF SE
  • Berkeley Advanced Biomaterials
  • Braskem
  • CAM Bioceramics BV
  • Celanese Corporation
  • CoorsTek, Inc.
  • Danimer Scientific
  • Dentsply Sirona Inc.
  • Dow Inc.
  • DSM-Firmenich AG
  • Evonik Industries AG
  • Invibio Ltd. by Victrex PLC
  • Johnson & Johnson
  • Medtronic Plc
  • MycoWorks
  • NatureWorks LLC
  • Novamont SpA
  • Smith & Nephew plc
  • Stryker Corporation
  • Terumo Corporation
  • Toray Industries, Inc.
  • TotalEnergies Corbion bv
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-434CCDA04CCF

The Biomaterials Market was valued at USD 49.94 billion in 2024 and is projected to grow to USD 56.07 billion in 2025, with a CAGR of 12.52%, reaching USD 101.37 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 49.94 billion
Estimated Year [2025] USD 56.07 billion
Forecast Year [2030] USD 101.37 billion
CAGR (%) 12.52%

In today's rapidly evolving technological and biomedical environment, biomaterials have emerged as a cornerstone for innovations in healthcare, research, and industry applications. The field has grown exponentially, driven by breakthroughs in science and the growing demand for materials that can seamlessly interact with biological systems. In recent years, researchers and industry leaders have turned to biomaterials to address challenges in medical device manufacturing, tissue engineering, and regenerative medicine. This progression is not only the result of advanced research techniques but also of the imperative need for sustainable and high-performance materials across various sectors.

The modern biomaterial market combines advanced composites, natural resources, and industrial-grade polymers with cutting-edge manufacturing processes. This convergence of technology has redefined the expectations and applications of these materials. Beyond improving patient outcomes in medical therapies, they have become instrumental in reducing the environmental footprint by providing eco-friendly alternatives in consumer goods and construction industries. Through rigorous testing, cross-disciplinary collaborations, and real-world deployment, the landscape of biomaterials is witnessing an era of rapid transformation.

The integration of biomaterials into diverse applications not only demands a deep understanding of material science but also a strategic outlook to harness their potential. Whether it is for developing implants that closely mimic human tissues or creating protective coatings for industrial applications, the evolution in biomaterials is reshaping the future. As the market continues its dynamic growth, stakeholders are keenly focused on blending innovation with industry standards to ensure both safety and efficiency in product deployment.

Transformative Shifts in the Biomaterials Landscape

Recent years have been characterized by significant shifts in the biomaterials domain, with transformative changes affecting every stage of the product lifecycle from research and development to manufacturing and commercialization. Emerging technologies, such as 3D printing and nanotechnology, have enabled the creation of materials with unparalleled precision. These innovations support the design of products that are not only more functional and durable but also tailored to meet specific medical and industrial needs.

One of the most impactful changes has been the integration of advanced simulation tools and data analytics into material design processes. These tools are now routinely employed to predict material behavior, optimize performance, and reduce the time between conceptualization and market introduction. As a result, investments in automated processes and digital transformation initiatives have skyrocketed. Regulatory agencies have also updated their frameworks to better address the intricacies of novel biomaterials, ensuring that safety standards remain robust while encouraging innovation.

Moreover, market leaders and research institutions worldwide are collaborating to bring next-generation biomaterials to the forefront of science. These collaborations focus on producing materials that are not only effective in clinical scenarios but also sustainable and cost-efficient. The rise of personalized medicine, along with an increasing emphasis on patient-specific solutions, further underscores the need for bespoke material properties. Unified strategies that leverage interdisciplinary expertise promise to propel the industry into a future where biomaterials can rapidly adapt to both clinical and industrial challenges.

This period of transformation underscores the urgency to reframe conventional approaches. As emerging trends converge with traditional practices, the biomaterials landscape is experiencing an era of creative energy and dynamic change that promises long-term growth and adaptability across a spectrum of applications.

Key Segmentation Insights Driving Market Dynamics

A thorough examination of the biomaterials market reveals a multitude of segmentation approaches that are essential for understanding its diverse nature. The segmentation based on type studies materials such as ceramics, metallic compounds, natural substances, and polymers. Each of these components exhibits unique properties that cater to different application demands in both high-performance sectors and cost-sensitive markets. In parallel, the classification segmentation dissects the market into bioactive materials, biocompatible materials, and bioinert materials. This division is critical as it distinguishes materials that actively interact with biological systems from those designed simply to be inert.

Equally instrumental in market assessment is the segmentation based on application. This lens examines the relevance of biomaterials in areas spanning cardiovascular implants, dental applications, orthopedic implants, surgical sutures, tissue engineering, and wound management. The application-based nuance provides a clear perspective on how biomaterials can be tailored to improve therapeutic outcomes in a variety of clinical settings. Moreover, by linking tissue-specific demands to material properties, stakeholders are better able to map research priorities and innovation pathways.

Complementing these insights, the segmentation based on end users sheds light on the final beneficiaries of these materials. The market is carefully studied in relation to the needs of biotechnology companies, hospitals, research laboratories, and specialty clinics. This segmentation enables a panoramic view of customer requirements and technological adaptability. In essence, these distinct yet interrelated segmentation strategies not only chart the current course of the biomaterials industry but also serve as a blueprint for strategic market planning and research and development initiatives.

Together, these segmentation criteria underscore the highly segmented yet integrated nature of the biomaterials market, highlighting potential areas for accelerated innovation, investment, and market expansion.

Based on Type, market is studied across Ceramics, Metallic, Natural, and Polymers.

Based on Classification, market is studied across Bioactive Materials, Biocompatible Materials, and Bioinert Materials.

Based on Application, market is studied across Cardiovascular, Dental Applications, Orthopedic Implants, Surgical Sutures, Tissue Engineering, and Wound Management.

Based on End User, market is studied across Biotechnology Companies, Hospitals, Research Laboratories, and Specialty Clinics.

Regional Insights Shaping Global Opportunities

Regional dynamics continue to play a pivotal role in shaping the trajectory of the biomaterials market. The Americas, with its strong research infrastructure, robust funding ecosystems, and a dynamic healthcare system, have emerged as a fertile ground for both innovation and commercialization of biomaterial technologies. Indeed, advancements in material science, coupled with a significant number of established medical device companies, are synergistically driving market growth in this region.

Europe, Middle East & Africa provide a contrasting yet equally stimulating market environment. Europe's mature regulatory framework and emphasis on sustainable practices often lead to highly refined market standards. At the same time, growing investment in research and public-private collaborations in the Middle East & Africa is catalyzing new opportunities, with emerging markets demonstrating rapid adoption rates driven by healthcare modernization efforts. This amalgamation of established practices and emerging innovations creates a supportive ecosystem for both incremental and breakthrough advances in biomaterials.

The Asia-Pacific region is experiencing accelerated growth spurred by rapid industrialization, increased health awareness, and robust government initiatives to boost research and development. The interplay of economic expansion and expanding consumer demand in this diverse region contributes to the rapid diffusion of innovative biomaterial solutions. Stakeholders in this market are increasingly focused on leveraging local talent and resources to create globally competitive solutions. In each of these regions, distinct regulatory environments, research priorities, and investment landscapes compliment the overall globalization of the biomaterials market, leading to varied growth trajectories and unique regional benefits.

As market forces continue to align with regional strengths, a convergence of technology, regulation, and consumer demand across these geographic segments paves the way for sustained global market expansion and diversification.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Shaping the Future of Biomaterials

An in-depth evaluation of key industry players reveals the pivotal role that major companies play in steering the biomaterials market towards the future. Dominant firms ranging from specialized innovators to global conglomerates have been influential in setting technological standards and driving competitive differentiation. Foundational enterprises such as Ametex Inc. and B. Braun Melsungen AG have consistently emphasized research and development, reinforcing their market positions through extensive product pipelines and breakthrough innovations.

Established names including BASF SE and Berkeley Advanced Biomaterials have augmented their legacy through strategic investments in cutting-edge research, often collaborating with academic institutions and research laboratories to drive technology refinement. Companies like Braskem, CAM Bioceramics B.V., and Celanese Corporation have expanded their portfolios to include sustainable and high-performance materials, marking a shift towards addressing both functional and environmental concerns in the industry. The influence of CoorsTek, Inc. and Danimer Scientific further exemplifies the market's dedication to continuous innovation by exploring novel processing techniques and material combinations.

Dentsply Sirona Inc. and Dow Inc. lead on innovation fronts by simultaneously catering to clinical and industrial demands. In this competitive landscape, other entities such as DSM-Firmenich AG, Evonik Industries AG, and Invibio Ltd. by Victrex PLC are responsible for pioneering success stories that uniquely blend functionality with regulatory compliance. These market leaders are complemented by stalwarts like Johnson & Johnson, Medtronic Plc, and MycoWorks who consistently drive the adoption of advanced biomaterial solutions. NatureWorks LLC, Novamont S.p.A., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, Toray Industries, Inc., TotalEnergies Corbion bv, along with Zimmer Biomet Holdings, Inc., collectively remain at the forefront of innovation, each tailoring their offerings to meet the growing demand for specialized, high-grade biomaterials.

These firms are actively expanding their research and market reach while simultaneously investing in new technologies to overcome the operational challenges posed by this rapidly evolving industry. Their research endeavors, coupled with strategic partnerships and a commitment to quality, continue to influence market trends, setting a benchmark for emerging players and established organizations alike.

The report delves into recent significant developments in the Biomaterials Market, highlighting leading vendors and their innovative profiles. These include Ametex Inc., B. Braun Melsungen AG, BASF SE, Berkeley Advanced Biomaterials, Braskem, CAM Bioceramics B.V., Celanese Corporation, CoorsTek, Inc., Danimer Scientific, Dentsply Sirona Inc., Dow Inc., DSM-Firmenich AG, Evonik Industries AG, Invibio Ltd. by Victrex PLC, Johnson & Johnson, Medtronic Plc, MycoWorks, NatureWorks LLC, Novamont S.p.A., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, Toray Industries, Inc., TotalEnergies Corbion bv, and Zimmer Biomet Holdings, Inc.. Actionable Recommendations for Industry Leaders

To navigate the evolving landscape of biomaterials, industry leaders must prioritize continuous innovation and strategic investments. It is imperative to commit resources to rigorous research and development programs that not only enhance material properties but also cater to the specific demands of various applications. Decision-makers should consider forging interdisciplinary collaborations that integrate the expertise of material scientists, engineers, and clinical professionals.

Investment in state-of-the-art technologies such as simulation software, advanced manufacturing techniques, and data analytics should become a cornerstone of any growth strategy. Proactive risk management, timely regulatory engagement, and an emphasis on sustainable practices can further fortify market positioning. Firm leadership must also remain agile in adapting to shifting market dynamics, embracing both incremental improvements and disruptive innovations to stay ahead of the curve. This strategic foresight will be key in addressing not only current challenges but also future opportunities within the biomaterials landscape.

Conclusion: Shaping the Future of Biomaterials

The evolution of biomaterials stands as a testament to the power of innovation in addressing complex challenges across healthcare and industrial applications. From enhancing patient outcomes to driving advances in manufacturing processes, the continuous integration of advanced materials and technologies is set to redefine the global market landscape. Strategic segmentation, regional dynamism, and the influence of market-leading companies collectively underscore the transformative potential that lies ahead.

In summary, the biomaterials market is witnessing a period of vibrant progress and opportunity. Organizations that proactively invest in research, leverage technology, and maintain agile operational frameworks will be best positioned to capitalize on the emerging trends. The convergence of scientific excellence and pragmatic market strategies promises to set new benchmarks in quality, functionality, and sustainability, paving the way for a future characterized by innovation and growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases creating a need for improved biomedical materials
      • 5.1.1.2. Increasing demand for sustainable and eco-friendly products driving biomaterials adoption
      • 5.1.1.3. Growing regulatory support and government incentives for sustainable and clean production
    • 5.1.2. Restraints
      • 5.1.2.1. Limited scalability and high manufacturing and development costs
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding investments in biotechnology research fostering new biomaterial innovations
      • 5.1.3.2. Emergence of innovative material processing techniques increasing biomaterials efficiency
    • 5.1.4. Challenges
      • 5.1.4.1. Biocompatibility and long-term safety concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing usage of ceramics for heat resistance and electrical insulation properties
    • 5.2.2. Application: Expansion of the cardiovascular sector drives the demand for biomaterials
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biomaterials Market, by Type

  • 6.1. Introduction
  • 6.2. Ceramics
  • 6.3. Metallic
  • 6.4. Natural
  • 6.5. Polymers

7. Biomaterials Market, by Classification

  • 7.1. Introduction
  • 7.2. Bioactive Materials
  • 7.3. Biocompatible Materials
  • 7.4. Bioinert Materials

8. Biomaterials Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular
  • 8.3. Dental Applications
  • 8.4. Orthopedic Implants
  • 8.5. Surgical Sutures
  • 8.6. Tissue Engineering
  • 8.7. Wound Management

9. Biomaterials Market, by End User

  • 9.1. Introduction
  • 9.2. Biotechnology Companies
  • 9.3. Hospitals
  • 9.4. Research Laboratories
  • 9.5. Specialty Clinics

10. Americas Biomaterials Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biomaterials Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biomaterials Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. MycoWorks introduces Rei-Tanning technology to elevate luxury-grade reishi biomaterials with enhanced durability
    • 13.3.2. Biomaterials startup Gozen launches first material
    • 13.3.3. Nordic SeaFarm and FutureLab & Partners launch Manatee Biomaterials to drive seaweed-based innovation for sustainable circular economy solutions
    • 13.3.4. Biomaterials Leader MycoWorks Announces Successful Harvest of First 1000 Sheets of Fine Mycelium and First Commercial Shipments, Paving Way for Product Launches
    • 13.3.5. IFF Launches Designed Enzymatic Biomaterials Technology Platform
    • 13.3.6. Biomaterials Start-up altM Raises USD 3.5 Million in Seed Funding from Omnivore, others
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ametex Inc.
  • 2. B. Braun Melsungen AG
  • 3. BASF SE
  • 4. Berkeley Advanced Biomaterials
  • 5. Braskem
  • 6. CAM Bioceramics B.V.
  • 7. Celanese Corporation
  • 8. CoorsTek, Inc.
  • 9. Danimer Scientific
  • 10. Dentsply Sirona Inc.
  • 11. Dow Inc.
  • 12. DSM-Firmenich AG
  • 13. Evonik Industries AG
  • 14. Invibio Ltd. by Victrex PLC
  • 15. Johnson & Johnson
  • 16. Medtronic Plc
  • 17. MycoWorks
  • 18. NatureWorks LLC
  • 19. Novamont S.p.A.
  • 20. Smith & Nephew plc
  • 21. Stryker Corporation
  • 22. Terumo Corporation
  • 23. Toray Industries, Inc.
  • 24. TotalEnergies Corbion bv
  • 25. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOMATERIALS MARKET MULTI-CURRENCY
  • FIGURE 2. BIOMATERIALS MARKET MULTI-LANGUAGE
  • FIGURE 3. BIOMATERIALS MARKET RESEARCH PROCESS
  • FIGURE 4. BIOMATERIALS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL BIOMATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BIOMATERIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES BIOMATERIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOMATERIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOMATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOMATERIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOMATERIALS MARKET SIZE, BY METALLIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOMATERIALS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOACTIVE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOCOMPATIBLE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOINERT MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOMATERIALS MARKET SIZE, BY SURGICAL SUTURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOMATERIALS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOMATERIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOMATERIALS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOMATERIALS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOMATERIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 197. BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2024